The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • 'cspec' property is found but contains no ID!

  • See Evidence submitted by expert panel for details.

Variant: NM_000152.5(GAA):c.2316G>T (p.Trp772Cys)

CA16607903

392862 (ClinVar)

Gene: GAA
Condition: glycogen storage disease II
Inheritance Mode: Autosomal recessive inheritance
UUID: 118c8346-2b31-42f6-8ca9-24f4c03b5bc1

HGVS expressions

NM_000152.5:c.2316G>T
NM_000152.5(GAA):c.2316G>T (p.Trp772Cys)
NC_000017.11:g.80117094G>T
CM000679.2:g.80117094G>T
NC_000017.10:g.78090893G>T
CM000679.1:g.78090893G>T
NC_000017.9:g.75705488G>T
NG_009822.1:g.20539G>T
ENST00000302262.8:c.2316G>T
ENST00000302262.7:c.2316G>T
ENST00000390015.7:c.2316G>T
ENST00000573556.1:n.269G>T
NM_000152.3:c.2316G>T
NM_001079803.1:c.2316G>T
NM_001079804.1:c.2316G>T
NM_000152.4:c.2316G>T
NM_001079803.2:c.2316G>T
NM_001079804.2:c.2316G>T
NM_001079803.3:c.2316G>T
NM_001079804.3:c.2316G>T

Uncertain Significance

Met criteria codes 3
PM2_Supporting PM5_Supporting PP3
Not Met criteria codes 2
PS3 PM3

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specifications for this VCEP
Evidence submitted by expert panel
Lysosomal Diseases VCEP
The NM_000152.5:c.2316G>T variant in GAA is a missense variant predicted to cause substitution of Tryptophan by Cysteine at amino acid 772 (p.Trp772Cys). This variant is absent in gnomAD v2.1.1 (PM2_Supporting). To our knowledge, the results of functional assays have not been reported for this variant and this variant has not been reported in the literature in any individuals with Pompe disease. The computational predictor REVEL gives a score of 0.942 which is above the threshold of 0.7, evidence that correlates with impact to GAA function (PP3). Another missense variant c.2314T>C (p.Trp772Arg) (PMID: 31619483, 18757064, ClinVar ID: 552527) in the same codon has been classified as likely pathogenic for Pompe disease by the ClinGen LSD VCEP (PM5_Supporting). There is a ClinVar entry for this variant (Variation ID: 392862, 2 star review status) with 3 submitters classifying the variant as Uncertain Significance. In summary, this variant meets the criteria to be classified as a Variant of Uncertain Significance for Pompe disease based on the ACMG/AMP criteria applied, as specified by the ClinGen Lysosomal Storage Disorders Variant Curation Expert panel (specifications Version 2.0): PP3, PM2_Supporting, PM5_Supporting.
Met criteria codes
PM2_Supporting
This variant is absent in gnomAD v2.1.1 (PM2_Supporting).
PM5_Supporting
Another missense variant c.2314T>C (p.Trp772Arg) (PMID: 31619483, 18757064, ClinVar ID: 552527) in the same codon has been classified as likely pathogenic for Pompe disease by the ClinGen LSD VCEP (PM5_Supporting).
PP3
The computational predictor REVEL gives a score of 0.942 which is above the threshold of 0.7, evidence that correlates with impact to GAA function (PP3).
Not Met criteria codes
PS3
To our knowledge, the results of functional assays have not been reported for this variant.
PM3
To our knowledge, this variant has not been reported in the literature in any individuals with Glycogen Storage Disease II.
Approved on: 2022-09-19
Published on: 2022-09-19
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.